Recently, an important milestone was reached at the Laviana Pharma Cangzhou GMP production base as the high-efficiency production line officially entered the production workshop and is now in operation. This move signifies another step forward for Laviana Pharma in production efficiency and product quality, injecting strong momentum into the company's long-term development.

The 2024 CPHI Worldwide, the world pharmaceutical raw materials exhibition, was held at FieraMilano in Milan, Italy from October 8th to 10th, 2024. Laviana Pharma showcased its one-stop CDMO professional services at this grand event, gathering more than 2.400 exhibitors from over 160 countries and 60.000 industry professionals from home and abroad to discuss cooperation, innovative research and development, and green, low-carbon sustainable development.

Recently, the BIONNOVA2024 Beijing Innovation Forum was successfully held in Beijing. This grand event brought together numerous elite professionals, academic authorities, and entrepreneurs in the pharmaceutical industry, showcasing the latest research achievements and market dynamics in the field of medicine. It also provided a platform for in-depth communication and collaboration among various parties. As a representative of a technology-driven Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical industry, Laviana Pharma appeared at the conference with its research and business teams.

Recently, Xin Changhai, Secretary of the Party Committee and Director of the Emergency Management Bureau of Dongli District, and Kang Zhenhong, Deputy Director and Senior Researcher, as well as Yan Guili, Party Branch Secretary, visited Laviana Pharma (Tianjin) Co., Ltd. for in-depth discussions and exchanges with the company's management team.

Recently, the Tianjin Municipal Science and Technology Bureau released the "Announcement of the Second Batch of Technology-based Small and Medium-sized Enterprises in Tianjin in 2024". Among them, Laviana Pharma (Tianjin) Co., Ltd. was selected for the second batch of technology-based small and medium-sized enterprises in Tianjin in 2024.

Recently, Laviana Pharma (Europe) Division – Laviana Pharma SAS – was officially inaugurated in Lyon, France. With the establishment of this European branch, Laviana Pharma 's international business strategy has taken another significant step forward, significantly enhancing the brand influence of Laviana Pharma within the global pharmaceutical industry. This marks a solid foundation for further deepening our presence in international markets.